New applications of automated peritoneal dialysis

doi:10.3877/cma.j.issn.2095-3216.2015.01.003

Abstract

Abstract:

Automated peritoneal dialysis (APD), with advantages including hemodynamic stability, no need for anticoagulation, strong volume control and solute removal ability, simple operation, safe and easy, and significantly improving quality of life, is especially suitable for patients with high or high-average peritoneal transport, insufficient clearance of solutes in continuous ambulatory peritoneal dialysis (CAPD), or recurrent peritonitis in CAPD. Moreover, APD can serve as an emergent dialysis mode suitable for acute kidney injury (AKI), urgent dialysis of end-stage renal disease (ESRD), refractory congestive heart failure, poisoning, acute pancreatitis, hyperpyrexia or hypothermia, hepatic failure, temporary dialysis during postoperative period of herniorrhaphy in peritoneal dialysis patients, and a new route of drug administration and liquid infusion. Besides, APD is an ideal renal replacement therapy for ESRD children.

Key words: Automated peritoneal dialysis, Acute kidney injury, End-stage renal disease, Refractory congestive heart failure

Zhaohui Ni, Haijiao Jin. New applications of automated peritoneal dialysis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(01): 10-13.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2015.01.003

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2015/V04/I01/10

References 22

[1]	Canadian Institute for Health Information. Canadian organ replacement register annual report: Treatment of end-stage organ failure in Canada, 2001 to 2010 [DB/OL]. Ottawa, Ontario, Canada: CIHI, 2011 [2015-04-08]. URL
[2]	United States Renal Data System. 2014 USRDS annual data report volume 2：end-stage renal disease [DB/OL]. Bethesda, MD: US Department of Public Health and Human Services, National Institutes of Health, 2014 [2015-04-08]. URL
[3]	Passadakis PS, Oreopoulos DG. Peritoneal dialysis in patients with acute renal failure [J]. Adv Perit Dial, 2007, 23(1): 7-16.
[4]	Chionh CY, Ronco C, Finkelstein FO, et al. Acute peritoneal dialysis: what is the 'adequate’ dose for acute kidney injury [J] ? Nephrol Dial Transplant, 2010, 25(10): 3155-3160.
[5]	Gabriel DP, Nascimento GV, Caramori JT, et al. High volume peritoneal dialysis for acute renal failure [J]. Perit Dial Int, 2007, 27(3): 277-282.
[6]	Ponce D, Berbel MN, Abrão JM, et al. A randomized clinical trial of high volume peritoneal dialysis versus extended daily hemodialysis for acute kidney injury patients [J]. Int Urol Nephrol, 2013, 45(3): 869-878.
[7]	Chionh CY, Soni SS, Finkelstein FO, et al. Use of peritoneal dialysis in AKI: a systematic review [J]. Clin J Am Soc Nephrol, 2013, 8(10): 1649-1660.
[8]	Lok C E, Foley R. Vascular access morbidity and mortality: trends of the last decade [J]. Clin J Am Soc Nephrol, 2013, 8(7): 1213-1219.
[9]	Povlsen JV, Ivarsen P. Assisted peritoneal dialysis: also for the late referred elderly patient [J]. Perit Dial Int, 2008, 28(5): 461-467.
[10]	Ghaffari A, Adeseun G, Patel UV. Urgent-start PD versus other modalities of dialysis: a prospective cohort study [Abstract]. J Am Soc Nephrol, 2013, 24: 100A.
[11]	Nair SK, Singh RS. Urgent start peritoneal dialysis: a centre′s experience [Abstract]. J Am Soc Nephrol, 2013, 24: 835A.
[12]	Liu Y, Zhang L, Lin A, et al. Impact of break-in period on the short-term outcomes of patients started on peritoneal dialysis [J]. Perit Dial Int, 2014, 34(1): 49-56.
[13]	Shah H, Chu M, Bargman JM. Perioperative management of peritoneal dialysis patients undergoing hernia surgery without the use of interim hemodialysis [J]. Perit Dial Int, 2006, 26(6): 684-687.
[14]	卞正乾，钟鸣，林爱武，等．腹膜透析病人合并腹壁疝的临床诊治体会[J]．外科理论与实践，2009, 14(4): 415-418.
[15]	Rosado C, Manzanedo R, Felipe C, et al. Role of different kinds of dialysis in the treatment of refractory heart failure [J] . J Biomed Sci Engineer, 2014, 7(01)：4-27.
[16]	Mehrotra R, Kathuria P. Place of peritoneal dialysis in the management of treatment-resistant congestive heart failure [J]. Kidney Int Suppl, 2006, (103): S67-S71.
[17]	Davies S, Lally F, Satchithananda D, et al. Extending the role of peritoneal dialysis: can we win hearts and minds [J] ? Nephrol Dial Transplant, 2014, 29(9): 1648-1654.
[18]	Courivaud C, Kazory A, Crepin T, et al. Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics [J]. Perit Dial Int, 2014, 34(1): 100-108.
[19]	Ni J, Verbavatz JM, Rippe A, et al. Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis [J]. Kidney Int, 2006, 69(9): 1518-1525.
[20]	Cnossen TT, Konings CJAM, Fagel WJ, et al. Fluid state and blood pressure control: no differences between APD and CAPD [J]. ASAIO J, 2012, 58(2): 132-136.
[21]	Ruhi Ç, Koçak H, Yavuz A, et al. Use of peritoneal ultrafiltration in the elderly refractory congestive heart failure patients [J]. Int Urol Nephrol, 2012, 44(3): 963-969.
[22]	Koch M, Kohnle M, Trapp R, et al. Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis [J]. Nephrol Dial Transplant, 2012, 27(1): 375-380.

Please choose a citation manager

Content to export